Model to Predict Node Negative Disease After Neoadjuvant Chemotherapy Using Data from the National Cancer Data Base

被引：0
|
作者：
Murphy, B. L. [1 ]
Hoskin, T. [1 ]
Day, C. [1 ]
Habermann, E. B. [1 ]
Boughey, J. C. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PT36
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [31] An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
    Blaye, C.
    Darbo, E.
    Debled, M.
    Brouste, V
    Velasco, V.
    Pinard, C.
    Larmonier, N.
    Pellegrin, I
    Tarricone, A.
    Arnedos, M.
    Commeny, J.
    Bonnefoi, H.
    Larmonier, C.
    MacGrogan, G.
    ESMO OPEN, 2022, 7 (04)
  • [32] Nomogram to predict sentinel lymph node involvement in patients with clinically node-negative breast cancer receiving neoadjuvant chemotherapy
    Allen, Lisa R.
    Gadgil, Pranjali V.
    Bassett, Roland
    Hunt, Kelly
    Mittendorf, Elizabeth Ann
    Yi, Min
    Babiera, Gildy
    Kuerer, Henry Mark
    Ross, Merrick I.
    Bedrosian, Isabelle
    Meric-Bernstam, Funda
    Hwang, Rosa F.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [33] Adjuvant Capecitabine after Neoadjuvant Chemotherapy in Triple Negative Breast Cancer with Lymph Node Metastasis
    Oner, Irem
    Turkel, Alper
    Karacin, Cengiz
    Seyran, Erdogan
    Tolunay, Pinar Kubilay
    Oksuzoglu, Omur Berna Cakmak
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (09): : 1012 - 1018
  • [34] Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer
    Pereira, Maria Fernanda Imperio
    Buzatto, Isabela Panzeri Carlotti
    Carrara, Helio Humberto Angotti
    Buono, Fabiana de Oliveira
    de Andrade, Jurandyr Moreira
    Orlandini, Leonardo Fleury
    Tiezzi, Daniel Guimaraes
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2024, 46
  • [35] Impact of Adjuvant Radiotherapy on Survival after Pancreatic Cancer Resection: An Appraisal of Data from the National Cancer Data Base
    Kooby, David A.
    Gillespie, Theresa W.
    Liu, Yuan
    Byrd-Sellers, Johnita
    Landry, Jerome
    Bian, John
    Lipscomb, Joseph
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (11) : 3634 - 3642
  • [36] Impact of Adjuvant Radiotherapy on Survival after Pancreatic Cancer Resection: An Appraisal of Data from the National Cancer Data Base
    David A. Kooby
    Theresa W. Gillespie
    Yuan Liu
    Johnita Byrd-Sellers
    Jerome Landry
    John Bian
    Joseph Lipscomb
    Annals of Surgical Oncology, 2013, 20 : 3634 - 3642
  • [37] Ovarian cancer patients selected for neoadjuvant chemotherapy vs. primary debulking surgery are not similar - A national cancer data base study
    Leiserowitz, G. S.
    Lin, J. F.
    Tergas, A. I.
    Cliby, W. A.
    Bristow, R. E.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 382 - 383
  • [38] Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit
    Spronk, Pauline E. R.
    Volders, Jose H.
    van den Tol, Petrousjka
    Smorenburg, Carolien H.
    Peeters, Marie-Jeanne T. F. D. Vrancken
    EJSO, 2019, 45 (02): : 110 - 117
  • [39] ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LYMPH NODE POSITIVE SQUAMOUS CELL CARCINOMA OF THE PENIS: ANALYSIS OF THE NATIONAL CANCER DATA BASE
    Raup, Valary
    Szymaniak, Julie
    Hanna, Nawar
    Berger, Alexandra
    Eswara, Jairam
    JOURNAL OF UROLOGY, 2019, 201 (04): : E709 - E709
  • [40] ASO Visual Abstract: Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy
    So, Alycia
    Yi, Min
    Simons, Janine M.
    Kuerer, Henry M.
    Caudle, Abigail
    Desnyder, Sarah M.
    Bedrosian, Isabelle
    Nead, Kevin T.
    Chavez-MacGregor, Mariana
    Teshome, Mediget
    Hunt, Kelly K.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (02) : 977 - 978
12345